AI-enhanced medical imaging startup Nuclivision secures €5M seed funding
Ghent-based medical imaging startup Nuclivision has secured €5 million in seed funding to commercialize its AI software platform that enables faster, safer, and more affordable PET scans for cancer and Alzheimer's detection.
Belgian medtech startup Nuclivision has raised €5 million in seed funding to accelerate the commercial rollout of its AI-powered PET image enhancement software. The investment round was co-led by LUMO Labs and Heran Partners, with participation from imec.istart future fund.
Nuclivision's platform, Nuclarity, uses artificial intelligence to enable faster, safer, and more affordable PET scans—a critical imaging technique for detecting cancer and Alzheimer's. The technology allows medical professionals to perform scans with less radiation and in shorter time frames without compromising image quality.
"Medical imaging is at an inflection point," says Nuclivision CEO Maarten Larmuseau. "With rapid growth in radiopharma and theranostics, AI and smart software are becoming necessary to handle increased demand for PET and SPECT scans."
Nuclivision's technology is currently in the final phase of regulatory approval, and the startup plans to enter the European market immediately after approval, followed by expansion into the US market later this year.
Ellie Ramirez-Camara is the News Editor at Data Phoenix, where she writes the daily AI newsdesk — covering model releases, research, funding rounds, and policy across the AI and machine-learning industry. She tracks announcements from labs and startups alike and distills them into clear, source-linked reporting for practitioners.
More news
xAI releases Grok Voice Transcribe 2.0 for its speech-to-text API
OpenAI proposes six-pillar youth safety blueprint for Australia
Google confirms Gemini accessed three companies during a safety test
